Dr. Jeffrey Warren Moses, MD

Dr. Moses practices at Columbia University Irving Medical Center in New York, New York.

Dr. Moses' NPI, 1447369368, was assigned on August 30, 2006. Dr. Moses graduated from Perelman School of Medicine - Philadelphia in 1974. Dr. Moses holds New York license 131950.

Dr. Moses' primary practice is Columbia University Irving Medical Center, at 622 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 297-4255.

Dr. Moses' primary practice is Columbia University Irving Medical Center in New York, New York. Dr. Moses is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Moses to 1 more hospital, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moses practices, 4 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Moses' primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Moses is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Moses' licenses on file in 3 states: New York, New Jersey and Pennsylvania.

Dmand AI lists angioplasty, cardiac catheterization and circulation problems among the conditions Dr. Moses treats.

CMS data shows 536 Medicare services from Dr. Moses across 14 procedure codes in 2024, for 130 Medicare patients. Medicare paid $89,845 for them.

CMS counts 130 Medicare patients who saw Dr. Moses in 2024. The largest group is 75 to 84, with 60 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Moses' median patient age at 74, with 17% women.

In 2024, Dr. Moses wrote 75 Medicare Part D claims for 27 patients. 64% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $281 in total drug cost. In 2018, CMS named 14 claims across 1 drug.

Dr. Moses accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 11 procedures of coronary angioplasty and stenting by Dr. Moses, more than 30% of the clinicians it reports for that procedure.

Dmand AI links 464 papers to Dr. Moses, published from 2003 to 2025. 2016 was the busiest year, with 28. The most frequent topics are Coronary Angiography, Percutaneous Coronary Intervention and Stents. Dr. Moses has published most often in Am J Cardiol. Dr. Moses' most frequent co-authors are Roxana Mehran, MD, George D. Dangas, MD and William Louis Lombardi, MD.

Dmand AI links Dr. Moses to 10 clinical trials, 3 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Coronary Artery Disease, Coronary Disease and Myocardial Infarction. Abbott Medical Devices sponsors the most, 2.

CMS Open Payments shows 1,225 general payments to Dr. Moses from 48 drug and device companies from 2016 to 2025. Ownership or investment make up the largest share, 28% of the total. Boston Scientific Corporation paid the most, $211,049. It also lists 5 research payments totaling $319 in 2023.

Dmand AI lists 9 awards for Dr. Moses, most recently America's Top Doctors in 2014.

Dr. Moses graduated from Perelman School of Medicine - Philadelphia in 1974. Dr. Moses is a member of ACC.

Dr. Moses is in network with 10 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.